Sean J Barbour
Overview
Explore the profile of Sean J Barbour including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1576
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghaddar M, Canney M, Barbour S
Semin Nephrol
. 2025 Mar;
:151564.
PMID: 40082162
Despite decades of research, our knowledge of the global epidemiology of IgA nephropathy remains limited. Much of what we know about IgA nephropathy incidence comes from biopsy registry studies that...
2.
Canney M, Atiquzzaman M, Zheng Y, Induruwage D, Zhao Y, Er L, et al.
Kidney Int
. 2024 Nov;
107(1):143-154.
PMID: 39515645
Patients with glomerular disease are at high risk of cardiovascular disease but the contribution of immunosuppression to this risk is unclear. In this retrospective cohort study of 1912 patients (comprised...
3.
Barratt J, Barbour S, Brenner R, Cooper K, Wei X, Eren N, et al.
J Am Soc Nephrol
. 2024 Oct;
PMID: 39462308
No abstract available.
4.
5.
Barbour S, Coppo R, Er L, Russo M, Liu Z, Ding J, et al.
Kidney Int
. 2024 Aug;
106(5):913-927.
PMID: 39094695
The pediatric International IgA Nephropathy (IgAN) Prediction Tool comprises two models with and without ethnicity and is the first method to predict the risk of a 30% decline in estimated...
6.
Kadatz M, Klarenbach S, So H, Fervenza F, Cattran D, Barbour S
Nephrol Dial Transplant
. 2024 Apr;
39(12):2058-2066.
PMID: 38621719
Background And Hypothesis: The MENTOR trial (MEmbranous Nephropathy Trial Of Rituximab) showed that rituximab was noninferior to cyclosporine in inducing complete or partial remission of proteinuria and was superior in...
7.
Barbour S, Coppo R, Er L, Pillebout E, Russo M, Alpers C, et al.
Clin J Am Soc Nephrol
. 2024 Jan;
19(4):438-451.
PMID: 38261310
Background: Nephritis is a common manifestation of IgA vasculitis and is morphologically indistinguishable from IgA nephropathy. While MEST-C scores are predictive of kidney outcomes in IgA nephropathy, their value in...
8.
Barratt J, Liew A, Yeo S, Fernstrom A, Barbour S, Sperati C, et al.
Clin J Am Soc Nephrol
. 2024 Jan;
19(4):452-462.
PMID: 38214599
Background: IgA nephropathy is the most common primary GN. Clinical features of IgA nephropathy include proteinuria, which is the strongest known surrogate of progression to kidney failure. Complement pathway activation...
9.
10.
Sethi S, Beck Jr L, Glassock R, Haas M, De Vriese A, Caza T, et al.
Mayo Clin Proc
. 2023 Oct;
98(11):1671-1684.
PMID: 37804268
Membranous nephropathy (MN) is a pattern of injury caused by autoantibodies binding to specific target antigens, with accumulation of immune complexes along the subepithelial region of glomerular basement membranes. The...